Administration can be tailored: oral delivery is convenient, leveraging GI tract stability for non-invasive dosing, while intranasal/intraventricular routes enable direct CNS targeting in advanced stages
Options: * Hemorrhoidectomy
You mix Collagen Peptides with a protein shake
The reason has been ascribed to loss of proteasome activity over time
The breadth of these trials suggests Lilly sees retatrutide as a cornerstone product with applications far beyond weight loss
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations